July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Funding drug development for rare ocular diseases - NIH mechanisms
Author Affiliations & Notes
  • Michael Steinmetz
    Division of Extramural Science Programs, National Eye Institute/NIH, Bethesda, Maryland, United States
  • Footnotes
    Commercial Relationships   Michael Steinmetz, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2584. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael Steinmetz; Funding drug development for rare ocular diseases - NIH mechanisms. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2584.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : This talk will describe mechanisms and funding available through the NEI for funding drug development for rare ocular diseases

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×